|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
129 a.a.
|
 |
|
|
|
|
|
|
|
211 a.a.
|
 |
|
|
|
|
|
|
|
196 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Growth factor/growth factor receptor
|
 |
|
Title:
|
 |
Crystal structure of a ternary fgf2-fgfr1-heparin complex
|
|
Structure:
|
 |
Fibroblast growth factor 2. Chain: a, b. Fragment: the b-trefoil core of fibroblast growth factor 2 synonym: fgf2. Engineered: yes. Mutation: yes. Fibroblast growth factor receptor 1. Chain: c, d. Fragment: extracellular ligand binding domain of fgf recept
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Octamer (from
)
|
|
Resolution:
|
 |
|
3.00Å
|
R-factor:
|
0.229
|
R-free:
|
0.282
|
|
|
Authors:
|
 |
J.Schlessinger,A.N.Plotnikov,O.A.Ibrahimi,A.V.Eliseenkova,B. A.Yayon,R.J.Linhardt,M.Mohammadi
|
Key ref:
|
 |
J.Schlessinger
et al.
(2000).
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
Mol Cell,
6,
743-750.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
04-Sep-00
|
Release date:
|
27-Sep-00
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P09038
(FGF2_HUMAN) -
Heparin-binding growth factor 2
|
|
|
|
Seq: Struc:
|
 |
 |
 |
288 a.a.
129 a.a.*
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains C, D:
E.C.2.7.10.1
- Receptor protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
|
 |
 |
 |
 |
 |
ATP
|
+
|
[protein]-L-tyrosine
|
=
|
ADP
|
+
|
[protein]-L-tyrosine phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
protein binding
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Mol Cell
6:743-750
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
|
|
J.Schlessinger,
A.N.Plotnikov,
O.A.Ibrahimi,
A.V.Eliseenkova,
B.K.Yeh,
A.Yayon,
R.J.Linhardt,
M.Mohammadi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of a dimeric 2:2:2 FGF:FGFR:heparin ternary complex at 3 A
resolution has been determined. Within each 1:1 FGF:FGFR complex, heparin makes
numerous contacts with both FGF and FGFR, thereby augmenting FGF-FGFR binding.
Heparin also interacts with FGFR in the adjoining 1:1 FGF:FGFR complex to
promote FGFR dimerization. The 6-O-sulfate group of heparin plays a pivotal role
in mediating both interactions. The unexpected stoichiometry of heparin binding
in the structure led us to propose a revised model for FGFR dimerization.
Biochemical data in support of this model are also presented. This model
provides a structural basis for FGFR activation by small molecule heparin
analogs and may facilitate the design of heparin mimetics capable of modulating
FGF signaling.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Electron Density Map of Decasaccharides Soaked
into Preformed Crystals of an FGF2-FGFR1 Complex(A) Location of
decasaccharides in the dimeric assemblage. Only the C[α] traces
of D2s (cyan) and FGFs (orange) are shown. The decasaccharides
are rendered in white sticks.(B) Stereo view of F[o] −F[c]
electron density map computed after simulated annealing with
decasaccharide omitted from the atomic model. The map is
computed at 3.0 Šresolution and contoured at 1.8 σ.
Sugar rings are labeled A through H starting at the nonreducing
end of the decasaccharide. Atom coloring is as follows: oxygens
in red, sulfurs in yellow, nitrogens in blue, and carbons in
gray. This figure was made using Bobscript ([4]).
|
 |
Figure 4.
Figure 4. The Two-End ModelMolecular surface representation
of the dimeric 2:2:2 FGF2-FGFR1-heparin ternary complex. The
view is from the top (same view as Figure 1A ) looking down into
the heparin binding canyon. Surface coloring is as follows: FGF2
in orange and D2 in green. Only the first six sugar rings of the
decasaccharides are rendered in ball-and-stick, and the
nonreducing and reducing ends are labeled. This figure was
created with GRASP ( [20]).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2000,
6,
743-750)
copyright 2000.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Langsdorf,
V.Schumacher,
X.Shi,
T.Tran,
J.Zaia,
S.Jain,
M.Taglienti,
J.A.Kreidberg,
A.Fine,
and
X.Ai
(2011).
Expression regulation and function of heparan sulfate 6-O-endosulfatases in the spermatogonial stem cell niche.
|
| |
Glycobiology, 21,
152-161.
|
 |
|
|
|
|
 |
A.Ruggiero,
F.Squeglia,
D.Marasco,
R.Marchetti,
A.Molinaro,
and
R.Berisio
(2011).
X-ray structural studies of the entire extracellular region of the serine/threonine kinase PrkC from Staphylococcus aureus.
|
| |
Biochem J, 435,
33-41.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.H.Biersmith,
M.Hammel,
E.R.Geisbrecht,
and
S.Bouyain
(2011).
The Immunoglobulin-like Domains 1 and 2 of the Protein Tyrosine Phosphatase LAR Adopt an Unusual Horseshoe-like Conformation.
|
| |
J Mol Biol, 408,
616-627.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.O.Staples,
X.Shi,
and
J.Zaia
(2011).
Glycomics Analysis of Mammalian Heparan Sulfates Modified by the Human Extracellular Sulfatase HSulf2.
|
| |
PLoS One, 6,
e16689.
|
 |
|
|
|
|
 |
G.S.Schultz,
J.M.Davidson,
R.S.Kirsner,
P.Bornstein,
and
I.M.Herman
(2011).
Dynamic reciprocity in the wound microenvironment.
|
| |
Wound Repair Regen, 19,
134-148.
|
 |
|
|
|
|
 |
J.Gupte,
L.Yang,
X.Wu,
J.Weiszmann,
R.Hecht,
B.Lemon,
R.Lindberg,
Z.Wang,
and
Y.Li
(2011).
The FGFR D3 domain determines receptor selectivity for fibroblast growth factor 21.
|
| |
J Mol Biol, 408,
491-502.
|
 |
|
|
|
|
 |
J.M.Dreyfuss,
C.Jacobs,
Y.Gindin,
G.Benson,
G.O.Staples,
and
J.Zaia
(2011).
Targeted analysis of glycomics liquid chromatography/mass spectrometry data.
|
| |
Anal Bioanal Chem, 399,
727-735.
|
 |
|
|
|
|
 |
K.Rose
(2011).
Interaction of ATP with fibroblast growth factor 2: biochemical characterization and consequence for growth factor stability.
|
| |
BMC Biochem, 12,
14.
|
 |
|
|
|
|
 |
N.A.Sunmonu,
K.Li,
and
J.Y.Li
(2011).
Numerous isoforms of Fgf8 reflect its multiple roles in the developing brain.
|
| |
J Cell Physiol, 226,
1722-1726.
|
 |
|
|
|
|
 |
A.K.Powell,
Y.A.Ahmed,
E.A.Yates,
and
J.E.Turnbull
(2010).
Generating heparan sulfate saccharide libraries for glycomics applications.
|
| |
Nat Protoc, 5,
821-833.
|
 |
|
|
|
|
 |
A.L.Ellis,
W.Pan,
G.Yang,
K.Jones,
C.Chuang,
J.M.Whitelock,
and
A.A.DeCarlo
(2010).
Similarity of recombinant human perlecan domain 1 by alternative expression systems bioactive heterogenous recombinant human perlecan D1.
|
| |
BMC Biotechnol, 10,
66.
|
 |
|
|
|
|
 |
B.C.Heng,
P.P.Bezerra,
Q.R.Meng,
D.W.Chin,
L.B.Koh,
H.Li,
H.Zhang,
P.R.Preiser,
F.Y.Boey,
and
S.S.Venkatraman
(2010).
Adhesion, proliferation, and gene expression profile of human umbilical vein endothelial cells cultured on bilayered polyelectrolyte coatings composed of glycosaminoglycans.
|
| |
Biointerphases, 5,
FA53-FA62.
|
 |
|
|
|
|
 |
B.Eckes,
R.Nischt,
and
T.Krieg
(2010).
Cell-matrix interactions in dermal repair and scarring.
|
| |
Fibrogenesis Tissue Repair, 3,
4.
|
 |
|
|
|
|
 |
B.Zhao,
C.Zhang,
K.Forsten-Williams,
J.Zhang,
and
M.Fannon
(2010).
Endothelial cell capture of heparin-binding growth factors under flow.
|
| |
PLoS Comput Biol, 6,
e1000971.
|
 |
|
|
|
|
 |
C.R.Degnin,
M.B.Laederich,
and
W.A.Horton
(2010).
FGFs in endochondral skeletal development.
|
| |
J Cell Biochem, 110,
1046-1057.
|
 |
|
|
|
|
 |
D.Leali,
R.Bianchi,
A.Bugatti,
S.Nicoli,
S.Mitola,
L.Ragona,
S.Tomaselli,
G.Gallo,
S.Catello,
V.Rivieccio,
L.Zetta,
and
M.Presta
(2010).
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide.
|
| |
J Cell Mol Med, 14,
2109-2121.
|
 |
|
|
|
|
 |
G.Ren,
J.Yin,
W.Wang,
L.Li,
and
D.Li
(2010).
Fibroblast growth factor (FGF)-21 signals through both FGF receptor-1 and 2.
|
| |
Sci China Life Sci, 53,
1000-1008.
|
 |
|
|
|
|
 |
G.Zimmer,
S.M.Schanuel,
S.Bürger,
F.Weth,
A.Steinecke,
J.Bolz,
and
R.Lent
(2010).
Chondroitin sulfate acts in concert with semaphorin 3A to guide tangential migration of cortical interneurons in the ventral telencephalon.
|
| |
Cereb Cortex, 20,
2411-2422.
|
 |
|
|
|
|
 |
H.Zhu,
L.Duchesne,
P.S.Rudland,
and
D.G.Fernig
(2010).
The heparan sulfate co-receptor and the concentration of fibroblast growth factor-2 independently elicit different signalling patterns from the fibroblast growth factor receptor.
|
| |
Cell Commun Signal, 8,
14.
|
 |
|
|
|
|
 |
J.Azzi,
A.S.Geara,
S.El-Sayegh,
and
R.Abdi
(2010).
Immunological aspects of pancreatic islet cell transplantation.
|
| |
Expert Rev Clin Immunol, 6,
111-124.
|
 |
|
|
|
|
 |
J.Dong,
S.Yao,
X.Zhou,
L.Zhang,
and
Y.Xu
(2010).
Synthesis of N-heteroaroyl aminosaccharide derivatives as fibroblast growth factor 2 signaling modulators.
|
| |
Chem Pharm Bull (Tokyo), 58,
1210-1215.
|
 |
|
|
|
|
 |
J.Gutiérrez,
and
E.Brandan
(2010).
A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation.
|
| |
Mol Cell Biol, 30,
1634-1649.
|
 |
|
|
|
|
 |
J.Ratelade,
C.Arrondel,
G.Hamard,
S.Garbay,
S.Harvey,
N.Biebuyck,
H.Schulz,
N.Hastie,
M.Pontoglio,
M.C.Gubler,
C.Antignac,
and
L.Heidet
(2010).
A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
|
| |
Hum Mol Genet, 19,
1.
|
 |
|
|
|
|
 |
M.J.Webber,
X.Han,
S.N.Murthy,
K.Rajangam,
S.I.Stupp,
and
J.W.Lomasney
(2010).
Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases.
|
| |
J Tissue Eng Regen Med, 4,
600-610.
|
 |
|
|
|
|
 |
M.Kuro-o
(2010).
Overview of the FGF23-Klotho axis.
|
| |
Pediatr Nephrol, 25,
583-590.
|
 |
|
|
|
|
 |
M.Kuro-o
(2010).
A potential link between phosphate and aging--lessons from Klotho-deficient mice.
|
| |
Mech Ageing Dev, 131,
270-275.
|
 |
|
|
|
|
 |
M.Ly,
T.N.Laremore,
and
R.J.Linhardt
(2010).
Proteoglycomics: recent progress and future challenges.
|
| |
OMICS, 14,
389-399.
|
 |
|
|
|
|
 |
O.J.Park,
H.J.Kim,
K.M.Woo,
J.H.Baek,
and
H.M.Ryoo
(2010).
FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization.
|
| |
J Biol Chem, 285,
3568-3574.
|
 |
|
|
|
|
 |
R.Gill,
L.Hitchins,
F.Fletcher,
and
G.K.Dhoot
(2010).
Sulf1A and HGF regulate satellite-cell growth.
|
| |
J Cell Sci, 123,
1873-1883.
|
 |
|
|
|
|
 |
T.Kobayashi,
H.Habuchi,
K.Nogami,
S.Ashikari-Hada,
K.Tamura,
H.Ide,
and
K.Kimata
(2010).
Functional analysis of chick heparan sulfate 6-O-sulfotransferases in limb bud development.
|
| |
Dev Growth Differ, 52,
146-156.
|
 |
|
|
|
|
 |
W.J.Kuo,
M.A.Digman,
and
A.D.Lander
(2010).
Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization.
|
| |
Mol Biol Cell, 21,
4028-4041.
|
 |
|
|
|
|
 |
X.Wu,
H.Ge,
B.Lemon,
S.Vonderfecht,
H.Baribault,
J.Weiszmann,
J.Gupte,
J.Gardner,
R.Lindberg,
Z.Wang,
and
Y.Li
(2010).
Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19).
|
| |
Proc Natl Acad Sci U S A, 107,
14158-14163.
|
 |
|
|
|
|
 |
Y.Hu,
and
P.M.Bouloux
(2010).
Novel insights in FGFR1 regulation: lessons from Kallmann syndrome.
|
| |
Trends Endocrinol Metab, 21,
385-393.
|
 |
|
|
|
|
 |
A.Beenken,
and
M.Mohammadi
(2009).
The FGF family: biology, pathophysiology and therapy.
|
| |
Nat Rev Drug Discov, 8,
235-253.
|
 |
|
|
|
|
 |
B.C.Melnik,
G.Schmitz,
and
C.C.Zouboulis
(2009).
Anti-acne agents attenuate FGFR2 signal transduction in acne.
|
| |
J Invest Dermatol, 129,
1868-1877.
|
 |
|
|
|
|
 |
E.V.Grigor'eva,
A.I.Shevchenko,
N.A.Mazurok,
E.A.Elisaphenko,
A.I.Zhelezova,
A.G.Shilov,
P.A.Dyban,
A.P.Dyban,
E.M.Noniashvili,
S.Y.Slobodyanyuk,
T.B.Nesterova,
N.Brockdorff,
and
S.M.Zakian
(2009).
FGF4 independent derivation of trophoblast stem cells from the common vole.
|
| |
PLoS One, 4,
e7161.
|
 |
|
|
|
|
 |
F.Zong,
E.Fthenou,
N.Wolmer,
P.Hollósi,
I.Kovalszky,
L.Szilák,
C.Mogler,
G.Nilsonne,
G.Tzanakakis,
and
K.Dobra
(2009).
Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells.
|
| |
PLoS One, 4,
e7346.
|
 |
|
|
|
|
 |
H.Ijiri,
F.Coulibaly,
G.Nishimura,
D.Nakai,
E.Chiu,
C.Takenaka,
K.Ikeda,
H.Nakazawa,
N.Hamada,
E.Kotani,
P.Metcalf,
S.Kawamata,
and
H.Mori
(2009).
Structure-based targeting of bioactive proteins into cypovirus polyhedra and application to immobilized cytokines for mammalian cell culture.
|
| |
Biomaterials, 30,
4297-4308.
|
 |
|
|
|
|
 |
H.P.Makarenkova,
M.P.Hoffman,
A.Beenken,
A.V.Eliseenkova,
R.Meech,
C.Tsau,
V.N.Patel,
R.A.Lang,
and
M.Mohammadi
(2009).
Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis.
|
| |
Sci Signal, 2,
ra55.
|
 |
|
|
|
|
 |
I.Kalus,
B.Salmen,
C.Viebahn,
K.von Figura,
D.Schmitz,
R.D'Hooge,
and
T.Dierks
(2009).
Differential involvement of the extracellular 6-O-endosulfatases Sulf1 and Sulf2 in brain development and neuronal and behavioural plasticity.
|
| |
J Cell Mol Med, 13,
4505-4521.
|
 |
|
|
|
|
 |
J.Gattineni,
C.Bates,
K.Twombley,
V.Dwarakanath,
M.L.Robinson,
R.Goetz,
M.Mohammadi,
and
M.Baum
(2009).
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.
|
| |
Am J Physiol Renal Physiol, 297,
F282-F291.
|
 |
|
|
|
|
 |
J.Jia,
M.Maccarana,
X.Zhang,
M.Bespalov,
U.Lindahl,
and
J.P.Li
(2009).
Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling.
|
| |
J Biol Chem, 284,
15942-15950.
|
 |
|
|
|
|
 |
J.Kalinina,
S.A.Byron,
H.P.Makarenkova,
S.K.Olsen,
A.V.Eliseenkova,
W.J.Larochelle,
M.Dhanabal,
S.Blais,
D.M.Ornitz,
L.A.Day,
T.A.Neubert,
P.M.Pollock,
and
M.Mohammadi
(2009).
Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix.
|
| |
Mol Cell Biol, 29,
4663-4678.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Moreaux,
A.C.Sprynski,
S.R.Dillon,
K.Mahtouk,
M.Jourdan,
A.Ythier,
P.Moine,
N.Robert,
E.Jourdan,
J.F.Rossi,
and
B.Klein
(2009).
APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
|
| |
Eur J Haematol, 83,
119-129.
|
 |
|
|
|
|
 |
J.N.Cash,
C.A.Rejon,
A.C.McPherron,
D.J.Bernard,
and
T.B.Thompson
(2009).
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.
|
| |
EMBO J, 28,
2662-2676.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Harada,
H.Murakami,
A.Okawa,
N.Okimoto,
S.Hiraoka,
T.Nakahara,
R.Akasaka,
Y.Shiraishi,
N.Futatsugi,
Y.Mizutani-Koseki,
A.Kuroiwa,
M.Shirouzu,
S.Yokoyama,
M.Taiji,
S.Iseki,
D.M.Ornitz,
and
H.Koseki
(2009).
FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion.
|
| |
Nat Genet, 41,
289-298.
|
 |
|
|
|
|
 |
M.Zakrzewska,
A.Wiedlocha,
A.Szlachcic,
D.Krowarsch,
J.Otlewski,
and
S.Olsnes
(2009).
Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.
|
| |
J Biol Chem, 284,
25388-25403.
|
 |
|
|
|
|
 |
O.Gorbenko,
G.Ovcharenko,
T.Klymenko,
O.Zhyvoloup,
N.Gaman,
D.Volkova,
I.Gout,
and
V.Filonenko
(2009).
Generation of monoclonal antibody targeting fibroblast growth factor receptor 3.
|
| |
Hybridoma (Larchmt), 28,
295-300.
|
 |
|
|
|
|
 |
Q.Zheng,
Y.Zhang,
Y.Chen,
N.Yang,
X.J.Wang,
and
D.Zhu
(2009).
Systematic identification of genes involved in divergent skeletal muscle growth rates of broiler and layer chickens.
|
| |
BMC Genomics, 10,
87.
|
 |
|
|
|
|
 |
S.Ashikari-Hada,
H.Habuchi,
N.Sugaya,
T.Kobayashi,
and
K.Kimata
(2009).
Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
|
| |
Glycobiology, 19,
644-654.
|
 |
|
|
|
|
 |
S.Ghanaati,
M.J.Webber,
R.E.Unger,
C.Orth,
J.F.Hulvat,
S.E.Kiehna,
M.Barbeck,
A.Rasic,
S.I.Stupp,
and
C.J.Kirkpatrick
(2009).
Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers.
|
| |
Biomaterials, 30,
6202-6212.
|
 |
|
|
|
|
 |
S.Li,
C.Christensen,
L.B.Køhler,
V.V.Kiselyov,
V.Berezin,
and
E.Bock
(2009).
Agonists of fibroblast growth factor receptor induce neurite outgrowth and survival of cerebellar granule neurons.
|
| |
Dev Neurobiol, 69,
837-854.
|
 |
|
|
|
|
 |
Y.Chen,
M.Mohammadi,
and
J.G.Flanagan
(2009).
Graded levels of FGF protein span the midbrain and can instruct graded induction and repression of neural mapping labels.
|
| |
Neuron, 62,
773-780.
|
 |
|
|
|
|
 |
Y.Hadari,
and
J.Schlessinger
(2009).
FGFR3-targeted mAb therapy for bladder cancer and multiple myeloma.
|
| |
J Clin Invest, 119,
1077-1079.
|
 |
|
|
|
|
 |
Y.Hu,
S.E.Guimond,
P.Travers,
S.Cadman,
E.Hohenester,
J.E.Turnbull,
S.H.Kim,
and
P.M.Bouloux
(2009).
Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.
|
| |
J Biol Chem, 284,
29905-29920.
|
 |
|
|
|
|
 |
Y.Luo,
C.Yang,
C.Jin,
R.Xie,
F.Wang,
and
W.L.McKeehan
(2009).
Novel phosphotyrosine targets of FGFR2IIIb signaling.
|
| |
Cell Signal, 21,
1370-1378.
|
 |
|
|
|
|
 |
A.Beermann,
and
R.Schröder
(2008).
Sites of Fgf signalling and perception during embryogenesis of the beetle Tribolium castaneum.
|
| |
Dev Genes Evol, 218,
153-167.
|
 |
|
|
|
|
 |
D.G.Seidler,
and
R.Dreier
(2008).
Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function?
|
| |
IUBMB Life, 60,
729-733.
|
 |
|
|
|
|
 |
J.Falardeau,
W.C.Chung,
A.Beenken,
T.Raivio,
L.Plummer,
Y.Sidis,
E.E.Jacobson-Dickman,
A.V.Eliseenkova,
J.Ma,
A.Dwyer,
R.Quinton,
S.Na,
J.E.Hall,
C.Huot,
N.Alois,
S.H.Pearce,
L.W.Cole,
V.Hughes,
M.Mohammadi,
P.Tsai,
and
N.Pitteloud
(2008).
Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.
|
| |
J Clin Invest, 118,
2822-2831.
|
 |
|
|
|
|
 |
J.P.Lai,
J.R.Thompson,
D.S.Sandhu,
and
L.R.Roberts
(2008).
Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.
|
| |
Future Oncol, 4,
803-814.
|
 |
|
|
|
|
 |
K.M.Ferguson
(2008).
Structure-based view of epidermal growth factor receptor regulation.
|
| |
Annu Rev Biophys, 37,
353-373.
|
 |
|
|
|
|
 |
K.R.Catlow,
J.A.Deakin,
Z.Wei,
M.Delehedde,
D.G.Fernig,
E.Gherardi,
J.T.Gallagher,
M.S.Pavão,
and
M.Lyon
(2008).
Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density.
|
| |
J Biol Chem, 283,
5235-5248.
|
 |
|
|
|
|
 |
K.Rajangam,
M.S.Arnold,
M.A.Rocco,
and
S.I.Stupp
(2008).
Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity.
|
| |
Biomaterials, 29,
3298-3305.
|
 |
|
|
|
|
 |
K.Rose,
S.Pallast,
S.Klumpp,
and
J.Krieglstein
(2008).
ATP-binding on fibroblast growth factor 2 partially overlaps with the heparin-binding domain.
|
| |
J Biochem, 144,
343-347.
|
 |
|
|
|
|
 |
K.Tan,
M.Duquette,
J.H.Liu,
K.Shanmugasundaram,
A.Joachimiak,
J.T.Gallagher,
A.C.Rigby,
J.H.Wang,
and
J.Lawler
(2008).
Heparin-induced cis- and trans-dimerization modes of the thrombospondin-1 N-terminal domain.
|
| |
J Biol Chem, 283,
3932-3941.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Kuro-o
(2008).
Endocrine FGFs and Klothos: emerging concepts.
|
| |
Trends Endocrinol Metab, 19,
239-245.
|
 |
|
|
|
|
 |
N.Fukuhara,
J.A.Howitt,
S.A.Hussain,
and
E.Hohenester
(2008).
Structural and functional analysis of slit and heparin binding to immunoglobulin-like domains 1 and 2 of Drosophila Robo.
|
| |
J Biol Chem, 283,
16226-16234.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Kulahin,
V.Kiselyov,
A.Kochoyan,
O.Kristensen,
J.S.Kastrup,
V.Berezin,
E.Bock,
and
M.Gajhede
(2008).
Dimerization effect of sucrose octasulfate on rat FGF1.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 64,
448-452.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.S.Gandhi,
and
R.L.Mancera
(2008).
The structure of glycosaminoglycans and their interactions with proteins.
|
| |
Chem Biol Drug Des, 72,
455-482.
|
 |
|
|
|
|
 |
N.Sugaya,
H.Habuchi,
N.Nagai,
S.Ashikari-Hada,
and
K.Kimata
(2008).
6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture.
|
| |
J Biol Chem, 283,
10366-10376.
|
 |
|
|
|
|
 |
S.Hussain,
M.Slevin,
S.Matou,
N.Ahmed,
M.I.Choudhary,
R.Ranjit,
D.West,
and
J.Gaffney
(2008).
Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.
|
| |
Angiogenesis, 11,
245-256.
|
 |
|
|
|
|
 |
S.J.Goodger,
C.J.Robinson,
K.J.Murphy,
N.Gasiunas,
N.J.Harmer,
T.L.Blundell,
D.A.Pye,
and
J.T.Gallagher
(2008).
Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms.
|
| |
J Biol Chem, 283,
13001-13008.
|
 |
|
|
|
|
 |
S.Nadanaka,
M.Ishida,
M.Ikegami,
and
H.Kitagawa
(2008).
Chondroitin 4-O-Sulfotransferase-1 Modulates Wnt-3a Signaling through Control of E Disaccharide Expression of Chondroitin Sulfate.
|
| |
J Biol Chem, 283,
27333-27343.
|
 |
|
|
|
|
 |
S.R.Pallerla,
R.Lawrence,
L.Lewejohann,
Y.Pan,
T.Fischer,
U.Schlomann,
X.Zhang,
J.D.Esko,
and
K.Grobe
(2008).
Altered heparan sulfate structure in mice with deleted NDST3 gene function.
|
| |
J Biol Chem, 283,
16885-16894.
|
 |
|
|
|
|
 |
V.N.Patel,
K.M.Likar,
S.Zisman-Rozen,
S.N.Cowherd,
K.S.Lassiter,
I.Sher,
E.A.Yates,
J.E.Turnbull,
D.Ron,
and
M.P.Hoffman
(2008).
Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation.
|
| |
J Biol Chem, 283,
9308-9317.
|
 |
|
|
|
|
 |
W.M.Abdel-Rahman,
J.Kalinina,
S.Shoman,
S.Eissa,
M.Ollikainen,
O.Elomaa,
A.V.Eliseenkova,
R.Bützow,
M.Mohammadi,
and
P.Peltomäki
(2008).
Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous beta-catenin.
|
| |
Hum Mutat, 29,
390-397.
|
 |
|
|
|
|
 |
W.Zhang,
Y.Chen,
M.R.Swift,
E.Tassi,
D.C.Stylianou,
K.A.Gibby,
A.T.Riegel,
and
A.Wellstein
(2008).
Effect of FGF-binding Protein 3 on Vascular Permeability.
|
| |
J Biol Chem, 283,
28329-28337.
|
 |
|
|
|
|
 |
X.Yue,
X.Li,
H.T.Nguyen,
D.R.Chin,
D.E.Sullivan,
and
J.A.Lasky
(2008).
Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo.
|
| |
J Biol Chem, 283,
20397-20407.
|
 |
|
|
|
|
 |
Y.Yamazaki,
T.Tamada,
N.Kasai,
I.Urakawa,
Y.Aono,
H.Hasegawa,
T.Fujita,
R.Kuroki,
T.Yamashita,
S.Fukumoto,
and
T.Shimada
(2008).
Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.
|
| |
J Bone Miner Res, 23,
1509-1518.
|
 |
|
|
|
|
 |
Y.Yang,
S.Yuzawa,
and
J.Schlessinger
(2008).
Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization.
|
| |
Proc Natl Acad Sci U S A, 105,
7681-7686.
|
 |
|
|
|
|
 |
B.C.Lin,
M.Wang,
C.Blackmore,
and
L.R.Desnoyers
(2007).
Liver-specific activities of FGF19 require Klotho beta.
|
| |
J Biol Chem, 282,
27277-27284.
|
 |
|
|
|
|
 |
C.Morlot,
N.M.Thielens,
R.B.Ravelli,
W.Hemrika,
R.A.Romijn,
P.Gros,
S.Cusack,
and
A.A.McCarthy
(2007).
Structural insights into the Slit-Robo complex.
|
| |
Proc Natl Acad Sci U S A, 104,
14923-14928.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.R.Holst,
H.Bou-Reslan,
B.B.Gore,
K.Wong,
D.Grant,
S.Chalasani,
R.A.Carano,
G.D.Frantz,
M.Tessier-Lavigne,
B.Bolon,
D.M.French,
and
A.Ashkenazi
(2007).
Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival.
|
| |
PLoS ONE, 2,
e575.
|
 |
|
|
|
|
 |
C.W.Vander Kooi,
M.A.Jusino,
B.Perman,
D.B.Neau,
H.D.Bellamy,
and
D.J.Leahy
(2007).
Structural basis for ligand and heparin binding to neuropilin B domains.
|
| |
Proc Natl Acad Sci U S A, 104,
6152-6157.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Gemma,
A.N.Hulme,
A.Jahnke,
L.Jin,
M.Lyon,
R.M.Müller,
and
D.Uhrín
(2007).
DMT-MM mediated functionalisation of the non-reducing end of glycosaminoglycans.
|
| |
Chem Commun (Camb), 0,
2686-2688.
|
 |
|
|
|
|
 |
E.L.Shipp,
and
L.C.Hsieh-Wilson
(2007).
Profiling the sulfation specificities of glycosaminoglycan interactions with growth factors and chemotactic proteins using microarrays.
|
| |
Chem Biol, 14,
195-208.
|
 |
|
|
|
|
 |
G.Su,
S.A.Blaine,
D.Qiao,
and
A.Friedl
(2007).
Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation.
|
| |
J Biol Chem, 282,
14906-14915.
|
 |
|
|
|
|
 |
G.Turashvili,
J.Bouchal,
K.Baumforth,
W.Wei,
M.Dziechciarkova,
J.Ehrmann,
J.Klein,
E.Fridman,
J.Skarda,
J.Srovnal,
M.Hajduch,
P.Murray,
and
Z.Kolar
(2007).
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
|
| |
BMC Cancer, 7,
55.
|
 |
|
|
|
|
 |
H.Mori,
C.Shukunami,
A.Furuyama,
H.Notsu,
Y.Nishizaki,
and
Y.Hiraki
(2007).
Immobilization of bioactive fibroblast growth factor-2 into cubic proteinous microcrystals (Bombyx mori cypovirus polyhedra) that are insoluble in a physiological cellular environment.
|
| |
J Biol Chem, 282,
17289-17296.
|
 |
|
|
|
|
 |
I.Shams,
E.Rohmann,
V.P.Eswarakumar,
E.D.Lew,
S.Yuzawa,
B.Wollnik,
J.Schlessinger,
and
I.Lax
(2007).
Lacrimo-auriculo-dento-digital syndrome is caused by reduced activity of the fibroblast growth factor 10 (FGF10)-FGF receptor 2 signaling pathway.
|
| |
Mol Cell Biol, 27,
6903-6912.
|
 |
|
|
|
|
 |
J.L.de Paz,
C.Noti,
F.Böhm,
S.Werner,
and
P.H.Seeberger
(2007).
Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers.
|
| |
Chem Biol, 14,
879-887.
|
 |
|
|
|
|
 |
M.A.Lemmon,
and
K.M.Ferguson
(2007).
A new twist in the transmembrane signaling tool-kit.
|
| |
Cell, 130,
213-215.
|
 |
|
|
|
|
 |
M.Roghani,
and
D.Moscatelli
(2007).
Prostate cells express two isoforms of fibroblast growth factor receptor 1 with different affinities for fibroblast growth factor-2.
|
| |
Prostate, 67,
115-124.
|
 |
|
|
|
|
 |
N.Kulahin,
V.Kiselyov,
A.Kochoyan,
O.Kristensen,
J.S.Kastrup,
V.Berezin,
E.Bock,
and
M.Gajhede
(2007).
Structure of rat acidic fibroblast growth factor at 1.4 A resolution.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 63,
65-68.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.M.Smallwood,
J.Williams,
Q.Xu,
D.J.Leahy,
and
J.Nathans
(2007).
Mutational analysis of Norrin-Frizzled4 recognition.
|
| |
J Biol Chem, 282,
4057-4068.
|
 |
|
|
|
|
 |
R.Goetz,
A.Beenken,
O.A.Ibrahimi,
J.Kalinina,
S.K.Olsen,
A.V.Eliseenkova,
C.Xu,
T.A.Neubert,
F.Zhang,
R.J.Linhardt,
X.Yu,
K.E.White,
T.Inagaki,
S.A.Kliewer,
M.Yamamoto,
H.Kurosu,
Y.Ogawa,
M.Kuro-o,
B.Lanske,
M.S.Razzaque,
and
M.Mohammadi
(2007).
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
|
| |
Mol Cell Biol, 27,
3417-3428.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.J.Kamerzell,
S.B.Joshi,
D.McClean,
L.Peplinskie,
K.Toney,
D.Papac,
M.Li,
and
C.R.Middaugh
(2007).
Parathyroid hormone is a heparin/polyanion binding protein: binding energetics and structure modification.
|
| |
Protein Sci, 16,
1193-1203.
|
 |
|
|
|
|
 |
T.Kobayashi,
H.Habuchi,
K.Tamura,
H.Ide,
and
K.Kimata
(2007).
Essential role of heparan sulfate 2-O-sulfotransferase in chick limb bud patterning and development.
|
| |
J Biol Chem, 282,
19589-19597.
|
 |
|
|
|
|
 |
V.P.Eswarakumar,
and
J.Schlessinger
(2007).
Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3.
|
| |
Proc Natl Acad Sci U S A, 104,
3937-3942.
|
 |
|
|
|
|
 |
V.Vreys,
and
G.David
(2007).
Mammalian heparanase: what is the message?
|
| |
J Cell Mol Med, 11,
427-452.
|
 |
|
|
|
|
 |
W.D.Tolbert,
J.Daugherty,
C.Gao,
Q.Xie,
C.Miranti,
E.Gherardi,
G.V.Woude,
and
H.E.Xu
(2007).
A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist.
|
| |
Proc Natl Acad Sci U S A, 104,
14592-14597.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Arai,
M.Fujita,
A.Marui,
K.Hirose,
H.Sakaguchi,
T.Ikeda,
Y.Tabata,
and
M.Komeda
(2007).
Combined treatment with sustained-release basic fibroblast growth factor and heparin enhances neovascularization in hypercholesterolemic mouse hindlimb ischemia.
|
| |
Circ J, 71,
412-417.
|
 |
|
|
|
|
 |
A.Canales,
R.Lozano,
B.López-Méndez,
J.Angulo,
R.Ojeda,
P.M.Nieto,
M.Martín-Lomas,
G.Giménez-Gallego,
and
J.Jiménez-Barbero
(2006).
Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue.
|
| |
FEBS J, 273,
4716-4727.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Canales-Mayordomo,
R.Fayos,
J.Angulo,
R.Ojeda,
M.Martín-Pastor,
P.M.Nieto,
M.Martín-Lomas,
R.Lozano,
G.Giménez-Gallego,
and
J.Jiménez-Barbero
(2006).
Backbone dynamics of a biologically active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue, by 15N NMR relaxation methods.
|
| |
J Biomol NMR, 35,
225-239.
|
 |
|
|
|
|
 |
A.Raghuraman,
P.D.Mosier,
and
U.R.Desai
(2006).
Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).
|
| |
J Med Chem, 49,
3553-3562.
|
 |
|
|
|
|
 |
E.Sanchez-Heras,
F.V.Howell,
G.Williams,
and
P.Doherty
(2006).
The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule.
|
| |
J Biol Chem, 281,
35208-35216.
|
 |
|
|
|
|
 |
F.Baba,
K.Swartz,
R.van Buren,
J.Eickhoff,
Y.Zhang,
W.Wolberg,
and
A.Friedl
(2006).
Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.
|
| |
Breast Cancer Res Treat, 98,
91-98.
|
 |
|
|
|
|
 |
G.Su,
K.Meyer,
C.D.Nandini,
D.Qiao,
S.Salamat,
and
A.Friedl
(2006).
Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells.
|
| |
Am J Pathol, 168,
2014-2026.
|
 |
|
|
|
|
 |
J.Kreuger,
D.Spillmann,
J.P.Li,
and
U.Lindahl
(2006).
Interactions between heparan sulfate and proteins: the concept of specificity.
|
| |
J Cell Biol, 174,
323-327.
|
 |
|
|
|
|
 |
K.Kamimura,
T.Koyama,
H.Habuchi,
R.Ueda,
M.Masu,
K.Kimata,
and
H.Nakato
(2006).
Specific and flexible roles of heparan sulfate modifications in Drosophila FGF signaling.
|
| |
J Cell Biol, 174,
773-778.
|
 |
|
|
|
|
 |
L.Duchesne,
B.Tissot,
T.R.Rudd,
A.Dell,
and
D.G.Fernig
(2006).
N-glycosylation of fibroblast growth factor receptor 1 regulates ligand and heparan sulfate co-receptor binding.
|
| |
J Biol Chem, 281,
27178-27189.
|
 |
|
|
|
|
 |
L.M.McDowell,
B.A.Frazier,
D.R.Studelska,
K.Giljum,
J.Chen,
J.Liu,
K.Yu,
D.M.Ornitz,
and
L.Zhang
(2006).
Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans.
|
| |
J Biol Chem, 281,
6924-6930.
|
 |
|
|
|
|
 |
M.A.Dupree,
S.R.Pollack,
E.M.Levine,
and
C.T.Laurencin
(2006).
Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: a whole cell model.
|
| |
Biophys J, 91,
3097-3112.
|
 |
|
|
|
|
 |
M.A.Weinreich,
I.Lintmaer,
L.Wang,
H.D.Liggitt,
M.A.Harkey,
and
C.A.Blau
(2006).
Growth factor receptors as regulators of hematopoiesis.
|
| |
Blood, 108,
3713-3721.
|
 |
|
|
|
|
 |
M.Ida,
T.Shuo,
K.Hirano,
Y.Tokita,
K.Nakanishi,
F.Matsui,
S.Aono,
H.Fujita,
Y.Fujiwara,
T.Kaji,
and
A.Oohira
(2006).
Identification and functions of chondroitin sulfate in the milieu of neural stem cells.
|
| |
J Biol Chem, 281,
5982-5991.
|
 |
|
|
|
|
 |
N.Jastrebova,
M.Vanwildemeersch,
A.C.Rapraeger,
G.Giménez-Gallego,
U.Lindahl,
and
D.Spillmann
(2006).
Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors.
|
| |
J Biol Chem, 281,
26884-26892.
|
 |
|
|
|
|
 |
N.Pitteloud,
J.S.Acierno,
A.Meysing,
A.V.Eliseenkova,
J.Ma,
O.A.Ibrahimi,
D.L.Metzger,
F.J.Hayes,
A.A.Dwyer,
V.A.Hughes,
M.Yialamas,
J.E.Hall,
E.Grant,
M.Mohammadi,
and
W.F.Crowley
(2006).
Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
|
| |
Proc Natl Acad Sci U S A, 103,
6281-6286.
|
 |
|
|
|
|
 |
R.Sasisekharan,
R.Raman,
and
V.Prabhakar
(2006).
Glycomics approach to structure-function relationships of glycosaminoglycans.
|
| |
Annu Rev Biomed Eng, 8,
181-231.
|
 |
|
|
|
|
 |
R.Villanueva,
N.Morales-Peza,
I.Castelán-Sánchez,
E.García-Villa,
R.Tapia,
A.Cid-Arregui,
A.García-Carrancá,
E.López-Bayghen,
and
P.Gariglio
(2006).
Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding.
|
| |
BMC Cancer, 6,
218.
|
 |
|
|
|
|
 |
S.A.Hussain,
M.Piper,
N.Fukuhara,
L.Strochlic,
G.Cho,
J.A.Howitt,
Y.Ahmed,
A.K.Powell,
J.E.Turnbull,
C.E.Holt,
and
E.Hohenester
(2006).
A molecular mechanism for the heparan sulfate dependence of slit-robo signaling.
|
| |
J Biol Chem, 281,
39693-39698.
|
 |
|
|
|
|
 |
S.K.Olsen,
J.Y.Li,
C.Bromleigh,
A.V.Eliseenkova,
O.A.Ibrahimi,
Z.Lao,
F.Zhang,
R.J.Linhardt,
A.L.Joyner,
and
M.Mohammadi
(2006).
Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.
|
| |
Genes Dev, 20,
185-198.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Maeda,
J.Desouky,
and
A.Friedl
(2006).
Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
|
| |
Oncogene, 25,
1408-1412.
|
 |
|
|
|
|
 |
V.P.Eswarakumar,
F.Ozcan,
E.D.Lew,
J.H.Bae,
F.Tomé,
C.J.Booth,
D.J.Adams,
I.Lax,
and
J.Schlessinger
(2006).
Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.
|
| |
Proc Natl Acad Sci U S A, 103,
18603-18608.
|
 |
|
|
|
|
 |
V.V.Kiselyov,
A.Kochoyan,
F.M.Poulsen,
E.Bock,
and
V.Berezin
(2006).
Elucidation of the mechanism of the regulatory function of the Ig1 module of the fibroblast growth factor receptor 1.
|
| |
Protein Sci, 15,
2318-2322.
|
 |
|
|
|
|
 |
V.V.Kiselyov,
E.Bock,
V.Berezin,
and
F.M.Poulsen
(2006).
NMR structure of the first Ig module of mouse FGFR1.
|
| |
Protein Sci, 15,
1512-1515.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.Zhang,
R.Swanson,
Y.Xiong,
B.Richard,
and
S.T.Olson
(2006).
Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
|
| |
J Biol Chem, 281,
37302-37310.
|
 |
|
|
|
|
 |
Y.Luo,
S.Ye,
M.Kan,
and
W.L.McKeehan
(2006).
Control of fibroblast growth factor (FGF) 7- and FGF1-induced mitogenesis and downstream signaling by distinct heparin octasaccharide motifs.
|
| |
J Biol Chem, 281,
21052-21061.
|
 |
|
|
|
|
 |
Y.Luo,
S.Ye,
M.Kan,
and
W.L.McKeehan
(2006).
Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb.
|
| |
J Cell Biochem, 97,
1241-1258.
|
 |
|
|
|
|
 |
Y.Y.Shao,
L.Wang,
and
R.T.Ballock
(2006).
Thyroid hormone and the growth plate.
|
| |
Rev Endocr Metab Disord, 7,
265-271.
|
 |
|
|
|
|
 |
A.Naggi,
B.Casu,
M.Perez,
G.Torri,
G.Cassinelli,
S.Penco,
C.Pisano,
G.Giannini,
R.Ishai-Michaeli,
and
I.Vlodavsky
(2005).
Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
|
| |
J Biol Chem, 280,
12103-12113.
|
 |
|
|
|
|
 |
A.Sebollela,
T.C.Cagliari,
G.S.Limaverde,
A.Chapeaurouge,
M.H.Sorgine,
T.Coelho-Sampaio,
C.H.Ramos,
and
S.T.Ferreira
(2005).
Heparin-binding sites in granulocyte-macrophage colony-stimulating factor. Localization and regulation by histidine ionization.
|
| |
J Biol Chem, 280,
31949-31956.
|
 |
|
|
|
|
 |
C.E.Holt,
and
B.J.Dickson
(2005).
Sugar codes for axons?
|
| |
Neuron, 46,
169-172.
|
 |
|
|
|
|
 |
C.I.Gama,
and
L.C.Hsieh-Wilson
(2005).
Chemical approaches to deciphering the glycosaminoglycan code.
|
| |
Curr Opin Chem Biol, 9,
609-619.
|
 |
|
|
|
|
 |
C.J.Robinson,
N.J.Harmer,
S.J.Goodger,
T.L.Blundell,
and
J.T.Gallagher
(2005).
Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes.
|
| |
J Biol Chem, 280,
42274-42282.
|
 |
|
|
|
|
 |
D.Rathore,
R.Nagarkatti,
D.Jani,
R.Chattopadhyay,
P.de la Vega,
S.Kumar,
and
T.F.McCutchan
(2005).
An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion.
|
| |
J Biol Chem, 280,
20524-20529.
|
 |
|
|
|
|
 |
G.Sajnani,
A.R.Aricescu,
E.Y.Jones,
J.Gallagher,
D.Alete,
and
A.Stoker
(2005).
PTPsigma promotes retinal neurite outgrowth non-cell-autonomously.
|
| |
J Neurobiol, 65,
59-71.
|
 |
|
|
|
|
 |
J.A.Joyce,
C.Freeman,
N.Meyer-Morse,
C.R.Parish,
and
D.Hanahan
(2005).
A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
|
| |
Oncogene, 24,
4037-4051.
|
 |
|
|
|
|
 |
J.Li,
J.Kleeff,
I.Abiatari,
H.Kayed,
N.A.Giese,
K.Felix,
T.Giese,
M.W.Büchler,
and
H.Friess
(2005).
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer.
|
| |
Mol Cancer, 4,
14.
|
 |
|
|
|
|
 |
K.Ingold,
A.Zumsteg,
A.Tardivel,
B.Huard,
Q.G.Steiner,
T.G.Cachero,
F.Qiang,
L.Gorelik,
S.L.Kalled,
H.Acha-Orbea,
P.D.Rennert,
J.Tschopp,
and
P.Schneider
(2005).
Identification of proteoglycans as the APRIL-specific binding partners.
|
| |
J Exp Med, 201,
1375-1383.
|
 |
|
|
|
|
 |
K.McDonnell,
E.T.Bowden,
R.Cabal-Manzano,
B.Hoxter,
A.T.Riegel,
and
A.Wellstein
(2005).
Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors.
|
| |
Lab Invest, 85,
747-755.
|
 |
|
|
|
|
 |
L.Dailey,
D.Ambrosetti,
A.Mansukhani,
and
C.Basilico
(2005).
Mechanisms underlying differential responses to FGF signaling.
|
| |
Cytokine Growth Factor Rev, 16,
233-247.
|
 |
|
|
|
|
 |
L.Jin,
P.E.Barran,
J.A.Deakin,
M.Lyon,
and
D.Uhrín
(2005).
Conformation of glycosaminoglycans by ion mobility mass spectrometry and molecular modelling.
|
| |
Phys Chem Chem Phys, 7,
3464-3471.
|
 |
|
|
|
|
 |
M.Goldfarb
(2005).
Fibroblast growth factor homologous factors: evolution, structure, and function.
|
| |
Cytokine Growth Factor Rev, 16,
215-220.
|
 |
|
|
|
|
 |
M.Mohammadi,
S.K.Olsen,
and
O.A.Ibrahimi
(2005).
Structural basis for fibroblast growth factor receptor activation.
|
| |
Cytokine Growth Factor Rev, 16,
107-137.
|
 |
|
|
|
|
 |
M.Mohammadi,
S.K.Olsen,
and
R.Goetz
(2005).
A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs.
|
| |
Curr Opin Struct Biol, 15,
506-516.
|
 |
|
|
|
|
 |
M.Morimoto-Tomita,
K.Uchimura,
A.Bistrup,
D.H.Lum,
M.Egeblad,
N.Boudreau,
Z.Werb,
and
S.D.Rosen
(2005).
Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer.
|
| |
Neoplasia, 7,
1001-1010.
|
 |
|
|
|
|
 |
O.A.Ibrahimi,
B.K.Yeh,
A.V.Eliseenkova,
F.Zhang,
S.K.Olsen,
M.Igarashi,
S.A.Aaronson,
R.J.Linhardt,
and
M.Mohammadi
(2005).
Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
|
| |
Mol Cell Biol, 25,
671-684.
|
 |
|
|
|
|
 |
T.M.Handel,
Z.Johnson,
S.E.Crown,
E.K.Lau,
and
A.E.Proudfoot
(2005).
Regulation of protein function by glycosaminoglycans--as exemplified by chemokines.
|
| |
Annu Rev Biochem, 74,
385-410.
|
 |
|
|
|
|
 |
V.P.Eswarakumar,
I.Lax,
and
J.Schlessinger
(2005).
Cellular signaling by fibroblast growth factor receptors.
|
| |
Cytokine Growth Factor Rev, 16,
139-149.
|
 |
|
|
|
|
 |
Z.L.Wu,
and
M.Lech
(2005).
Characterizing the non-reducing end structure of heparan sulfate.
|
| |
J Biol Chem, 280,
33749-33755.
|
 |
|
|
|
|
 |
C.Dodé,
and
J.P.Hardelin
(2004).
Kallmann syndrome: fibroblast growth factor signaling insufficiency?
|
| |
J Mol Med, 82,
725-734.
|
 |
|
|
|
|
 |
J.Angulo,
R.Ojeda,
J.L.de Paz,
R.Lucas,
P.M.Nieto,
R.M.Lozano,
M.Redondo-Horcajo,
G.Giménez-Gallego,
and
M.Martín-Lomas
(2004).
The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1.
|
| |
Chembiochem, 5,
55-61.
|
 |
|
|
|
|
 |
J.P.Lai,
J.R.Chien,
D.R.Moser,
J.K.Staub,
I.Aderca,
D.P.Montoya,
T.A.Matthews,
D.M.Nagorney,
J.M.Cunningham,
D.I.Smith,
E.L.Greene,
V.Shridhar,
and
L.R.Roberts
(2004).
hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.
|
| |
Gastroenterology, 126,
231-248.
|
 |
|
|
|
|
 |
J.S.Lee,
and
C.B.Chien
(2004).
When sugars guide axons: insights from heparan sulphate proteoglycan mutants.
|
| |
Nat Rev Genet, 5,
923-935.
|
 |
|
|
|
|
 |
J.Y.Cho,
C.Guo,
M.Torello,
G.P.Lunstrum,
T.Iwata,
C.Deng,
and
W.A.Horton
(2004).
Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.
|
| |
Proc Natl Acad Sci U S A, 101,
609-614.
|
 |
|
|
|
|
 |
K.Nakano,
Y.Okada,
K.Saito,
and
Y.Tanaka
(2004).
Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
|
| |
Arthritis Rheum, 50,
2450-2458.
|
 |
|
|
|
|
 |
K.Nogami,
H.Suzuki,
H.Habuchi,
N.Ishiguro,
H.Iwata,
and
K.Kimata
(2004).
Distinctive expression patterns of heparan sulfate O-sulfotransferases and regional differences in heparan sulfate structure in chick limb buds.
|
| |
J Biol Chem, 279,
8219-8229.
|
 |
|
|
|
|
 |
M.Banerjee,
J.Copp,
D.Vuga,
M.Marino,
T.Chapman,
P.van der Geer,
and
P.Ghosh
(2004).
GW domains of the Listeria monocytogenes invasion protein InlB are required for potentiation of Met activation.
|
| |
Mol Microbiol, 52,
257-271.
|
 |
|
|
|
|
 |
R.J.Linhardt
(2004).
Heparin-induced cancer cell death.
|
| |
Chem Biol, 11,
420-422.
|
 |
|
|
|
|
 |
R.T.Böttcher,
N.Pollet,
H.Delius,
and
C.Niehrs
(2004).
The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling.
|
| |
Nat Cell Biol, 6,
38-44.
|
 |
|
|
|
|
 |
S.K.Olsen,
O.A.Ibrahimi,
A.Raucci,
F.Zhang,
A.V.Eliseenkova,
A.Yayon,
C.Basilico,
R.J.Linhardt,
J.Schlessinger,
and
M.Mohammadi
(2004).
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity.
|
| |
Proc Natl Acad Sci U S A, 101,
935-940.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.R.Hanson,
M.D.Best,
and
C.H.Wong
(2004).
Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility.
|
| |
Angew Chem Int Ed Engl, 43,
5736-5763.
|
 |
|
|
|
|
 |
S.Shaunak,
S.Thomas,
E.Gianasi,
A.Godwin,
E.Jones,
I.Teo,
K.Mireskandari,
P.Luthert,
R.Duncan,
S.Patterson,
P.Khaw,
and
S.Brocchini
(2004).
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation.
|
| |
Nat Biotechnol, 22,
977-984.
|
 |
|
|
|
|
 |
S.Wang,
X.Ai,
S.D.Freeman,
M.E.Pownall,
Q.Lu,
D.S.Kessler,
and
C.P.Emerson
(2004).
QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis.
|
| |
Proc Natl Acad Sci U S A, 101,
4833-4838.
|
 |
|
|
|
|
 |
V.K.Ganesh,
S.A.Smith,
G.J.Kotwal,
and
K.H.Murthy
(2004).
Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.
|
| |
Proc Natl Acad Sci U S A, 101,
8924-8929.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Z.Shriver,
S.Raguram,
and
R.Sasisekharan
(2004).
Glycomics: a pathway to a class of new and improved therapeutics.
|
| |
Nat Rev Drug Discov, 3,
863-873.
|
 |
|
|
|
|
 |
A.Facchiano,
K.Russo,
A.M.Facchiano,
F.De Marchis,
F.Facchiano,
D.Ribatti,
M.S.Aguzzi,
and
M.C.Capogrossi
(2003).
Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties.
|
| |
J Biol Chem, 278,
8751-8760.
|
 |
|
|
|
|
 |
B.K.Yeh,
M.Igarashi,
A.V.Eliseenkova,
A.N.Plotnikov,
I.Sher,
D.Ron,
S.A.Aaronson,
and
M.Mohammadi
(2003).
Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.
|
| |
Proc Natl Acad Sci U S A, 100,
2266-2271.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Ito,
Y.Saitoh,
Y.Fujita,
Y.Yamazaki,
T.Imamura,
S.Oka,
and
S.Suzuki
(2003).
Decapeptide with fibroblast growth factor (FGF)-5 partial sequence inhibits hair growth suppressing activity of FGF-5.
|
| |
J Cell Physiol, 197,
272-283.
|
 |
|
|
|
|
 |
D.Qiao,
K.Meyer,
C.Mundhenke,
S.A.Drew,
and
A.Friedl
(2003).
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells. Specific role for glypican-1 in glioma angiogenesis.
|
| |
J Biol Chem, 278,
16045-16053.
|
 |
|
|
|
|
 |
D.Rathore,
S.C.Hrstka,
J.B.Sacci,
P.De la Vega,
R.J.Linhardt,
S.Kumar,
and
T.F.McCutchan
(2003).
Molecular mechanism of host specificity in Plasmodium falciparum infection: role of circumsporozoite protein.
|
| |
J Biol Chem, 278,
40905-40910.
|
 |
|
|
|
|
 |
J.H.Bassett,
and
G.R.Williams
(2003).
The molecular actions of thyroid hormone in bone.
|
| |
Trends Endocrinol Metab, 14,
356-364.
|
 |
|
|
|
|
 |
J.Schlessinger
(2003).
Signal transduction. Autoinhibition control.
|
| |
Science, 300,
750-752.
|
 |
|
|
|
|
 |
K.L.Kramer,
and
H.J.Yost
(2003).
Heparan sulfate core proteins in cell-cell signaling.
|
| |
Annu Rev Genet, 37,
461-484.
|
 |
|
|
|
|
 |
K.M.Ferguson,
M.B.Berger,
J.M.Mendrola,
H.S.Cho,
D.J.Leahy,
and
M.A.Lemmon
(2003).
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
|
| |
Mol Cell, 11,
507-517.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Borgenström,
M.Jalkanen,
and
M.Salmivirta
(2003).
Sulfated derivatives of Escherichia coli K5 polysaccharides as modulators of fibroblast growth factor signaling.
|
| |
J Biol Chem, 278,
49882-49889.
|
 |
|
|
|
|
 |
M.J.García-García,
and
K.V.Anderson
(2003).
Essential role of glycosaminoglycans in Fgf signaling during mouse gastrulation.
|
| |
Cell, 114,
727-737.
|
 |
|
|
|
|
 |
M.P.Machner,
S.Frese,
W.D.Schubert,
V.Orian-Rousseau,
E.Gherardi,
J.Wehland,
H.H.Niemann,
and
D.W.Heinz
(2003).
Aromatic amino acids at the surface of InlB are essential for host cell invasion by Listeria monocytogenes.
|
| |
Mol Microbiol, 48,
1525-1536.
|
 |
|
|
|
|
 |
R.Raman,
G.Venkataraman,
S.Ernst,
V.Sasisekharan,
and
R.Sasisekharan
(2003).
Structural specificity of heparin binding in the fibroblast growth factor family of proteins.
|
| |
Proc Natl Acad Sci U S A, 100,
2357-2362.
|
 |
|
|
|
|
 |
S.K.Olsen,
M.Garbi,
N.Zampieri,
A.V.Eliseenkova,
D.M.Ornitz,
M.Goldfarb,
and
M.Mohammadi
(2003).
Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs.
|
| |
J Biol Chem, 278,
34226-34236.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Merkulova-Rainon,
P.England,
S.Ding,
C.Demerens,
and
G.Tobelem
(2003).
The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor.
|
| |
J Biol Chem, 278,
37400-37408.
|
 |
|
|
|
|
 |
W.Nickel
(2003).
The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes.
|
| |
Eur J Biochem, 270,
2109-2119.
|
 |
|
|
|
|
 |
X.Ai,
A.T.Do,
O.Lozynska,
M.Kusche-Gullberg,
U.Lindahl,
and
C.P.Emerson
(2003).
QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling.
|
| |
J Cell Biol, 162,
341-351.
|
 |
|
|
|
|
 |
X.Coumoul,
and
C.X.Deng
(2003).
Roles of FGF receptors in mammalian development and congenital diseases.
|
| |
Birth Defects Res C Embryo Today, 69,
286-304.
|
 |
|
|
|
|
 |
Z.Kato,
J.Jee,
H.Shikano,
M.Mishima,
I.Ohki,
H.Ohnishi,
A.Li,
K.Hashimoto,
E.Matsukuma,
K.Omoya,
Y.Yamamoto,
T.Yoneda,
T.Hara,
N.Kondo,
and
M.Shirakawa
(2003).
The structure and binding mode of interleukin-18.
|
| |
Nat Struct Biol, 10,
966-971.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Z.L.Wu,
L.Zhang,
T.Yabe,
B.Kuberan,
D.L.Beeler,
A.Love,
and
R.D.Rosenberg
(2003).
The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex.
|
| |
J Biol Chem, 278,
17121-17129.
|
 |
|
|
|
|
 |
A.I.Arunkumar,
S.Srisailam,
T.K.Kumar,
K.M.Kathir,
Y.H.Chi,
H.M.Wang,
G.G.Chang,
I.Chiu,
and
C.Yu
(2002).
Structure and stability of an acidic fibroblast growth factor from Notophthalmus viridescens.
|
| |
J Biol Chem, 277,
46424-46432.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.I.Arunkumar,
T.K.Kumar,
K.M.Kathir,
S.Srisailam,
H.M.Wang,
P.S.Leena,
Y.H.Chi,
H.C.Chen,
C.H.Wu,
R.T.Wu,
G.G.Chang,
I.M.Chiu,
and
C.Yu
(2002).
Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity.
|
| |
Protein Sci, 11,
1050-1061.
|
 |
|
|
|
|
 |
A.K.Powell,
D.G.Fernig,
and
J.E.Turnbull
(2002).
Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate. Implications for dynamic assembly of a ternary signaling complex.
|
| |
J Biol Chem, 277,
28554-28563.
|
 |
|
|
|
|
 |
A.R.Aricescu,
I.W.McKinnell,
W.Halfter,
and
A.W.Stoker
(2002).
Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma.
|
| |
Mol Cell Biol, 22,
1881-1892.
|
 |
|
|
|
|
 |
B.K.Yeh,
A.V.Eliseenkova,
A.N.Plotnikov,
D.Green,
J.Pinnell,
T.Polat,
A.Gritli-Linde,
R.J.Linhardt,
and
M.Mohammadi
(2002).
Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate.
|
| |
Mol Cell Biol, 22,
7184-7192.
|
 |
|
|
|
|
 |
B.M.Loo,
and
M.Salmivirta
(2002).
Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
|
| |
J Biol Chem, 277,
32616-32623.
|
 |
|
|
|
|
 |
D.Rathore,
J.B.Sacci,
P.de la Vega,
and
T.F.McCutchan
(2002).
Binding and invasion of liver cells by Plasmodium falciparum sporozoites. Essential involvement of the amino terminus of circumsporozoite protein.
|
| |
J Biol Chem, 277,
7092-7098.
|
 |
|
|
|
|
 |
H.Ogiso,
R.Ishitani,
O.Nureki,
S.Fukai,
M.Yamanaka,
J.H.Kim,
K.Saito,
A.Sakamoto,
M.Inoue,
M.Shirouzu,
and
S.Yokoyama
(2002).
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
|
| |
Cell, 110,
775-787.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.Capila,
and
R.J.Linhardt
(2002).
Heparin-protein interactions.
|
| |
Angew Chem Int Ed Engl, 41,
391-412.
|
 |
|
|
|
|
 |
J.D.Esko,
and
S.B.Selleck
(2002).
Order out of chaos: assembly of ligand binding sites in heparan sulfate.
|
| |
Annu Rev Biochem, 71,
435-471.
|
 |
|
|
|
|
 |
J.Kreuger,
T.Matsumoto,
| | |